< Back to companies
Humane Genomics

Humane Genomics

Engineered viruses to defeat cancer

New York, NY, US

Humane Genomics focuses on engineering viruses to selectively kill cancer cells.

Humane Genomics logo
Get Involved in Humane Genomics

Problem Statement

Cancer treatments often lack the specificity to target and eliminate malignant cells without harming healthy tissue.

Core Technology

engineering viruses to selectively kill cancer cells

Key Differentiators

Engineering viruses to selectively target and kill cancer cells

Clinical Focus

Oncology

Company Info

Website
humanegenomics.com

Categories

Drug Discovery/Development

Disease Areas

Technologies

biotech

Clinical & IP

🔬

Clinical Validation

In vivo mouse models demonstrate safety profile and 50% tumor volume reduction. Lead candidate entering GMP manufacturing (Genezen partnership, Nov 2025). Preclinical path to IND application underway.

MedStartr Index Score

?
19

What do you think of Humane Genomics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Humane Genomics